Part 11 meeting canceled
This article was originally published in The Gray Sheet
Executive Summary
Public meeting on FDA's regulation of electronic records and signatures will not be rescheduled, following cancellation to observe the passing of former President Ronald Reagan. All comments and presentations should be submitted to docket number 2004N-0133 for FDA's consideration...
You may also be interested in...
Part 11 Redux? Comment Period Extension, Meeting Rescheduling Mulled
FDA is considering reopening the comment period on the electronic records and signatures rule and may reschedule a public meeting to discuss changes, according to agency staff
Who’s Hired? Hikma Recruits New US Generics President
A flurry of top level recruitments made headlines in the past weeks, with the likes of Hikma, Lupin, and Viatris announcing new hires while focusing on their targets for the year.
Organon And Henlius Complete Phase III For Denosumab
Having earlier this year reported positive Phase I data for their partnered denosumab biosimilar candidate, Organon and Shanghai Henlius Biotech have now announced that their HLX14 version has met primary endpoints in a Phase III study.